The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gastrointestinal Therapeutics Market Research Report 2025
Synopsis
Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
The global Gastrointestinal Therapeutics market was valued at US$ 34130 million in 2023 and is anticipated to reach US$ 50460 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Therapeutics.
Report Scope
The Gastrointestinal Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastrointestinal Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen
Segment by Type
Oral
Parenteral
Segment by Application
IBD
Irritable Bowel Syndrome (IBS)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
The global Gastrointestinal Therapeutics market was valued at US$ 34130 million in 2023 and is anticipated to reach US$ 50460 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Therapeutics.
Report Scope
The Gastrointestinal Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastrointestinal Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen
Segment by Type
Oral
Parenteral
Segment by Application
IBD
Irritable Bowel Syndrome (IBS)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Gastrointestinal Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 IBD
1.3.3 Irritable Bowel Syndrome (IBS)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Therapeutics Market Perspective (2019-2030)
2.2 Gastrointestinal Therapeutics Growth Trends by Region
2.2.1 Global Gastrointestinal Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gastrointestinal Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Gastrointestinal Therapeutics Market Dynamics
2.3.1 Gastrointestinal Therapeutics Industry Trends
2.3.2 Gastrointestinal Therapeutics Market Drivers
2.3.3 Gastrointestinal Therapeutics Market Challenges
2.3.4 Gastrointestinal Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Therapeutics Players by Revenue
3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
3.4 Global Gastrointestinal Therapeutics Market Concentration Ratio
3.4.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2023
3.5 Gastrointestinal Therapeutics Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Therapeutics Product Solution and Service
3.7 Date of Enter into Gastrointestinal Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Therapeutics Breakdown Data by Type
4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2025-2030)
5 Gastrointestinal Therapeutics Breakdown Data by Application
5.1 Global Gastrointestinal Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gastrointestinal Therapeutics Market Size (2019-2030)
6.2 North America Gastrointestinal Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gastrointestinal Therapeutics Market Size by Country (2019-2024)
6.4 North America Gastrointestinal Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Therapeutics Market Size (2019-2030)
7.2 Europe Gastrointestinal Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gastrointestinal Therapeutics Market Size by Country (2019-2024)
7.4 Europe Gastrointestinal Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Gastrointestinal Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Therapeutics Market Size (2019-2030)
9.2 Latin America Gastrointestinal Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gastrointestinal Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Gastrointestinal Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Gastrointestinal Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Gastrointestinal Therapeutics Introduction
11.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Gastrointestinal Therapeutics Introduction
11.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.2.5 Allergan Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction
11.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Gastrointestinal Therapeutics Introduction
11.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.4.5 Takeda Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Gastrointestinal Therapeutics Introduction
11.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Gastrointestinal Therapeutics Introduction
11.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Gastrointestinal Therapeutics Introduction
11.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.7.5 Merck Recent Development
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Detail
11.8.2 F. Hoffmann-La Roche Business Overview
11.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction
11.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.8.5 F. Hoffmann-La Roche Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction
11.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.9.5 Eli Lilly Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction
11.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.10.5 AstraZeneca Recent Development
11.11 Procter & Gamble
11.11.1 Procter & Gamble Company Detail
11.11.2 Procter & Gamble Business Overview
11.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction
11.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.11.5 Procter & Gamble Recent Development
11.12 Tillotts Pharma
11.12.1 Tillotts Pharma Company Detail
11.12.2 Tillotts Pharma Business Overview
11.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction
11.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.12.5 Tillotts Pharma Recent Development
11.13 Takeda
11.13.1 Takeda Company Detail
11.13.2 Takeda Business Overview
11.13.3 Takeda Gastrointestinal Therapeutics Introduction
11.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.13.5 Takeda Recent Development
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Detail
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction
11.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.14.5 GlaxoSmithKline Recent Development
11.15 Amgen
11.15.1 Amgen Company Detail
11.15.2 Amgen Business Overview
11.15.3 Amgen Gastrointestinal Therapeutics Introduction
11.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2019-2024)
11.15.5 Amgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral
Table 4. Global Gastrointestinal Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Gastrointestinal Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Gastrointestinal Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Gastrointestinal Therapeutics Market Share by Region (2019-2024)
Table 8. Global Gastrointestinal Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Gastrointestinal Therapeutics Market Share by Region (2025-2030)
Table 10. Gastrointestinal Therapeutics Market Trends
Table 11. Gastrointestinal Therapeutics Market Drivers
Table 12. Gastrointestinal Therapeutics Market Challenges
Table 13. Gastrointestinal Therapeutics Market Restraints
Table 14. Global Gastrointestinal Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Gastrointestinal Therapeutics Market Share by Players (2019-2024)
Table 16. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2023)
Table 17. Ranking of Global Top Gastrointestinal Therapeutics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gastrointestinal Therapeutics Product Solution and Service
Table 21. Date of Enter into Gastrointestinal Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gastrointestinal Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Gastrointestinal Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Gastrointestinal Therapeutics Revenue Market Share by Application (2019-2024)
Table 29. Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Gastrointestinal Therapeutics Revenue Market Share by Application (2025-2030)
Table 31. North America Gastrointestinal Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Gastrointestinal Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Gastrointestinal Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Gastrointestinal Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Gastrointestinal Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Gastrointestinal Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Gastrointestinal Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gastrointestinal Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Gastrointestinal Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Gastrointestinal Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Gastrointestinal Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. AbbVie Company Detail
Table 47. AbbVie Business Overview
Table 48. AbbVie Gastrointestinal Therapeutics Product
Table 49. AbbVie Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 50. AbbVie Recent Development
Table 51. Allergan Company Detail
Table 52. Allergan Business Overview
Table 53. Allergan Gastrointestinal Therapeutics Product
Table 54. Allergan Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Allergan Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Gastrointestinal Therapeutics Product
Table 59. Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Takeda Company Detail
Table 62. Takeda Business Overview
Table 63. Takeda Gastrointestinal Therapeutics Product
Table 64. Takeda Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Novartis Company Detail
Table 67. Novartis Business Overview
Table 68. Novartis Gastrointestinal Therapeutics Product
Table 69. Novartis Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Gastrointestinal Therapeutics Product
Table 74. Pfizer Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Merck Company Detail
Table 77. Merck Business Overview
Table 78. Merck Gastrointestinal Therapeutics Product
Table 79. Merck Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 80. Merck Recent Development
Table 81. F. Hoffmann-La Roche Company Detail
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product
Table 84. F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 85. F. Hoffmann-La Roche Recent Development
Table 86. Eli Lilly Company Detail
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Gastrointestinal Therapeutics Product
Table 89. Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 90. Eli Lilly Recent Development
Table 91. AstraZeneca Company Detail
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Gastrointestinal Therapeutics Product
Table 94. AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. Procter & Gamble Company Detail
Table 97. Procter & Gamble Business Overview
Table 98. Procter & Gamble Gastrointestinal Therapeutics Product
Table 99. Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 100. Procter & Gamble Recent Development
Table 101. Tillotts Pharma Company Detail
Table 102. Tillotts Pharma Business Overview
Table 103. Tillotts Pharma Gastrointestinal Therapeutics Product
Table 104. Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 105. Tillotts Pharma Recent Development
Table 106. Takeda Company Detail
Table 107. Takeda Business Overview
Table 108. Takeda Gastrointestinal Therapeutics Product
Table 109. Takeda Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 110. Takeda Recent Development
Table 111. GlaxoSmithKline Company Detail
Table 112. GlaxoSmithKline Business Overview
Table 113. GlaxoSmithKline Gastrointestinal Therapeutics Product
Table 114. GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 115. GlaxoSmithKline Recent Development
Table 116. Amgen Company Detail
Table 117. Amgen Business Overview
Table 118. Amgen Gastrointestinal Therapeutics Product
Table 119. Amgen Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
Table 120. Amgen Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gastrointestinal Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Oral Features
Figure 4. Parenteral Features
Figure 5. Global Gastrointestinal Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Gastrointestinal Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. IBD Case Studies
Figure 8. Irritable Bowel Syndrome (IBS) Case Studies
Figure 9. Gastrointestinal Therapeutics Report Years Considered
Figure 10. Global Gastrointestinal Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Gastrointestinal Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Gastrointestinal Therapeutics Market Share by Region: 2023 VS 2030
Figure 13. Global Gastrointestinal Therapeutics Market Share by Players in 2023
Figure 14. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics Revenue in 2023
Figure 16. North America Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Gastrointestinal Therapeutics Market Share by Country (2019-2030)
Figure 18. United States Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Gastrointestinal Therapeutics Market Share by Country (2019-2030)
Figure 22. Germany Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Gastrointestinal Therapeutics Market Share by Region (2019-2030)
Figure 30. China Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Gastrointestinal Therapeutics Market Share by Country (2019-2030)
Figure 38. Mexico Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Gastrointestinal Therapeutics Market Share by Country (2019-2030)
Figure 42. Turkey Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. AbbVie Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 45. Allergan Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 46. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 47. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 48. Novartis Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 50. Merck Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 51. F. Hoffmann-La Roche Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 52. Eli Lilly Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 53. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 54. Procter & Gamble Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 55. Tillotts Pharma Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 56. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 58. Amgen Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
